Halozyme Therapeutics, Inc. (HALO)

Market price: $128.50

6 valuation methods

• EV / Revenue: $38.88 to $159.98 (midpoint $53.18)
• EV / Gross Profit: $47.28 to $110.51 (midpoint $71.31)
• EV / EBITDA: $60.33 to $233.72 (midpoint $116.86)
• P / E: $71.31 to $242.94 (midpoint $143.20)
• DCF (FCFF): $156.94 to $224.85 (midpoint $185.34)
• P / E — adjusted: $95.30 to $285.88 (midpoint $193.85)